AU2002247945A1 - Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof - Google Patents
Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereofInfo
- Publication number
- AU2002247945A1 AU2002247945A1 AU2002247945A AU2002247945A AU2002247945A1 AU 2002247945 A1 AU2002247945 A1 AU 2002247945A1 AU 2002247945 A AU2002247945 A AU 2002247945A AU 2002247945 A AU2002247945 A AU 2002247945A AU 2002247945 A1 AU2002247945 A1 AU 2002247945A1
- Authority
- AU
- Australia
- Prior art keywords
- manufacture
- venlafaxine hydrochloride
- crystalline polymorphs
- polymorphs
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 229960002416 venlafaxine hydrochloride Drugs 0.000 title 1
- QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1177/MUM/2001 | 2001-12-13 | ||
| IN1177MU2001 | 2001-12-13 | ||
| PCT/IN2002/000046 WO2003050074A1 (en) | 2001-12-13 | 2002-03-19 | Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002247945A1 true AU2002247945A1 (en) | 2003-06-23 |
Family
ID=11097336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002247945A Abandoned AU2002247945A1 (en) | 2001-12-13 | 2002-03-19 | Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002247945A1 (en) |
| WO (1) | WO2003050074A1 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020183553A1 (en) * | 2000-10-19 | 2002-12-05 | Ben-Zion Dolitzky | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| TW200523258A (en) * | 2003-10-02 | 2005-07-16 | Wyeth Corp | Process for the preparation of 1-[cyano(phenyl)methyl]-cyclohexanol compounds |
| DE10359154A1 (en) | 2003-12-16 | 2005-07-28 | Krka Tovarna Zdravil, D.D. | Process for the preparation of venlafaxine and venlafaxine hydrochloride Form I |
| WO2006035457A1 (en) * | 2004-09-17 | 2006-04-06 | Amoli Organics Ltd. | A process for the manufacture of venlafaxine and intermediates thereof |
| CN100364966C (en) * | 2005-04-14 | 2008-01-30 | 上海雅本化学有限公司 | Process of synthesizing 1-[2-amino-1-(p-methoxylphenyl)-ethyl] cyclohexanol formate |
| AR062064A1 (en) * | 2006-07-14 | 2008-10-15 | Medichem Sa | IMPROVED PRICES TO PREPARE A BASE OF VENLAFAXINE AND ITS SALTS |
| CN104529797A (en) * | 2014-12-05 | 2015-04-22 | 南昌市博泽康医药科技有限公司 | Preparation of venlafaxine hydrochloride chiral crystal form |
| CN112920062B (en) * | 2021-01-26 | 2024-04-02 | 合肥立方制药股份有限公司 | Method for synthesizing venlafaxine by utilizing fixed bed hydrogenation equipment |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4761501A (en) * | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
| UA77145C2 (en) * | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
| CN1240206A (en) * | 1999-06-17 | 2000-01-05 | 华东理工大学 | Process for preparing 1[2-(dimethyamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloridumi |
| HUP0303496A3 (en) * | 2000-10-19 | 2005-08-29 | Teva Pharma | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof |
| AU2002212340B2 (en) * | 2000-10-31 | 2006-12-14 | Sandoz Ag | Crystalline forms of venlafaxine hydrochloride |
| WO2002046140A1 (en) * | 2000-12-07 | 2002-06-13 | Dr. Reddy's Laboratories Ltd. | Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation |
-
2002
- 2002-03-19 WO PCT/IN2002/000046 patent/WO2003050074A1/en not_active Ceased
- 2002-03-19 AU AU2002247945A patent/AU2002247945A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003050074A1 (en) | 2003-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL196287A0 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof | |
| AU2003235435A1 (en) | Crystalline forms of quetiapine hemifumarate | |
| HUP0500753A3 (en) | Crystalline forms of valacyclovir hydrochloride | |
| AU1234002A (en) | Crystalline forms of venlafaxine hydrochloride | |
| SI1432683T1 (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation | |
| AU2002330453A1 (en) | Crystals of hydroxynorephedrine derivative | |
| AU2002305162A1 (en) | Polymorphs of fexofenadine hydrochloride | |
| AU2003245029A1 (en) | Novel crystalline forms of donepezil hydrochloride | |
| IL162255A0 (en) | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof | |
| IL162171A0 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
| AU2002247945A1 (en) | Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof | |
| IL159266A0 (en) | Crystalline forms of fexofenadine and processes for the preparation thereof | |
| AU2001235970A1 (en) | Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation | |
| AU2003262928A1 (en) | Crystalline form of nateglinide and process for preparation thereof | |
| EP1238585B8 (en) | Use of esterquats | |
| AU2002357701A1 (en) | Polymorphs of fexofenadine base | |
| AU2003298725A1 (en) | Preparation of metallotexaphyrins | |
| AU2003300874A1 (en) | Crystalline forms of gatifloxacin and processes for preparation | |
| HK1065777A (en) | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof | |
| AU2002360409A1 (en) | Methods and intermediates for the synthesis of azepines | |
| AU2002347399A1 (en) | Venlafaxine hydrochloride polymorphs | |
| AU2002359898A1 (en) | Preparation of alpha-diimines | |
| HK1056545A (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
| AU2002238356A1 (en) | New use of phencynonate hydrochloride | |
| AU2002237189A1 (en) | New use of phencynonate hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |